The Program

The First Step to a World of Possibilities

According to the March of Dimes, one out of every 10 pregnancies in the U.S. results in a premature birth. Infants who survive premature birth face a higher risk of developing neurological complications, such as cerebral palsy, where no treatment options currently exist. With the Newborn Possibilities Program, we can make a difference.

The Newborn Possibilities Program is a first-of-its-kind initiative launched by Cord Blood Registry's (CBR) Center for Regenerative Medicine in collaboration with a select group of leading U.S. medical institutions. The program was jointly launched in March by CBR, Tucson Medical Center (TMC) and two prominent advocacy organizations based in Tucson, Save the Cord Foundation and Watching Over Mothers and Babies Foundation (WOMB). Read Press Release

The Newborn Possibilities Fund was created to provide financial assistance to families who have difficulty participating in a cord blood stem cell research study for their child because of significant expenses, like travel costs or lost days at work. One of the first trials being supported by the fund is the Medical College of Georgia clinical trial studying the use of cord blood stem cells to treat cerebral palsy. Read Medical College of Georgia's Press Release

The goal of Newborn Possibilities is to ensure that children born at-risk for neurological damage are given every opportunity to participate in new medical research using their own newborn stem cells.

Donate Today

The Program in Action

Working with leading medical facilities that can identify children who may be at risk for certain neurological disorders, Cord Blood Registry will provide cord blood banking services at no cost to eligible families. With Tucson Medical Center as the pilot medical institution, the program is expected to enroll nearly 700 children in itsfirst year. These families may then be able to participate in groundbreaking research using their children's own cord blood stem cells. And, the Newborn Possibilities Fund will help defray the associated costs for these families.

In January 2010, the first-FDA approved human clinical trial evaluating the use of a child's own cord blood stem cells in the treatment of cerebral palsy began at the Medical College of Georgia. As the only stem cell bank to participate in the trial, Cord Blood Registry and the Newborn Possibilities Program are playing a critical role in helping researchers identify study participants. As other similar clinical trials are initiated, the program will continue to help advance this groundbreaking research.

Read Press Release

Donate Today

Donate to the Newborn Possibilities Fund to help defray costs for families participating in ground-breaking therapeutic research using cord blood stem cells.